Product Information
CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.1756 per EA under NDC 72888015601. Its NADAC has been published 68 times since Mar 12, 2025.
Strength
50; 200 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888015601
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA217482On Market Since
6/4/2024
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 68 times since Mar 12, 2025, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1756 per EA |
|---|---|
| All-time high | $0.2186 (Aug 13, 2025) |
| All-time low | $0.1756 (Jun 17, 2026) |
| 52-week high | $0.2186 |
| 52-week low | $0.1756 |
| Median price | $0.1996 |
| Average price | $0.1982 |
| Largest weekly change | +8.1% (Mar 19, 2025) |
| Weeks tracked | 68 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Advagen Pharma Ltd., is $0.1756 per EA (NDC 72888015601), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 9.0%. It has been tracked across 68 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?
Since Mar 12, 2025, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1756 (Jun 17, 2026) to a high of $0.2186 (Aug 13, 2025), with a median of $0.1996 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CARBIDOPA-LEVO ER 50-200 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?
CARBIDOPA-LEVO ER 50-200 TAB (NDC 72888015601) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification